Peptide Custom Synthesis 7-ọjọ Sowo

Pese awọn ọna iwadii ti o ṣeeṣe pupọ fun
peptide sáyẹnsì
Ifo Cleanroom
0 Kilasi
Adani lesese soke si 100AA
0 AA
Ẹgbẹ iyipada Peptide 300+
0 +
Yan lati robi si 99% mimọ.
0 +

Awọn iṣẹ ati awọn ọja

Aṣa Peptide Synthesis

· 99% mimọ
Lati miligiramu-kg
· Awọn ilana adani titi di 200AA

Awọn Peptides ikunra

· Tripeptide-1;GHK-Cu
· Acetyl hexapeptide-8
· imolara-8;AHK- Ku

Peptide katalogi

· Awọn Peptides Antijeni
· Awọn peptides antimicrobial
Peptide ti nwọle sẹẹli

Awọn iyipada

· Eru isotope-aami
· C-ebute; N-ebute
.Glycopeptides;cyclic Peptide

Ifi aami peptide

· Biotinlation
· Aami Filuorisenti
· Antibody Asami

Peptide CRO

· Apẹrẹ ati Synthesis
· Idagbasoke ilana
·Oluranlowo lati tun nkan se

Idanwo peptide

· MS;HPLC;PH
· Iwa mimọ; Akoonu
· Endotoxin

Bawo ni lati ṣe dara julọ

Kilasi 100 Yara mimọ

Lati igbesẹ akọkọ ni ibẹrẹ ti idanwo naa si igbesẹ ti o kẹhin ti apoti, o ti wa ni nigbagbogbo pa ni a ifo ati ki o mọ ayika.

Aládàáṣiṣẹ erin ati ilana: Sẹmi-ara; air titẹ; ọriniinitutu; otutu; eruku patikulu ti wa ni laifọwọyi sile ati ofin.

Organic ati Biological Meji ase Technical Team

Awọn onimọ-ẹrọ wa wa lati awọn aaye ti kemistri Organic ati isedale, ati pe o ti ni oye ọpọlọpọ awọn ọna iṣelọpọ peptide, pẹlu kolaginni peptide ala-alakoso, idapọ peptide olomi-alakoso, ni idapo olomi-ri to peptide kolaginni, onidakeji ri to-alakoso peptide kolaginni, ati makirobia bakteria.

Iṣakoso didara: Ayẹwo ti ara ẹni gẹgẹbi ipilẹ lati ṣe igbelaruge iṣẹ naa.

Gbigba iriri iṣaaju bi ipin ti ironu ati gbero pe ko le ṣe ipinnu fun gbogbo ilana iṣelọpọ, o ti di koodu pipe ti ihuwasi lati ta ku lori idanwo leralera jakejado gbogbo ilana ati lati wakọ ilana atẹle pẹlu data gangan bi ẹri atilẹyin, eyiti o pẹlu itupalẹ awọn patikulu ni agbegbe; ọriniinitutu; otutu; titẹ; ati mimọ; akoonu; endotoxin; iye PH; ailesabiyamo ni gbóògì, ati bẹbẹ lọ.

Awọn ohun elo iṣelọpọ: peptide kolaginni si lyophilization, lati mg to kg

Lati miligiramu ti awọn peptides ti adani fun iwadii ijinle sayensi si kg ti awọn peptides ikunra, a ni gbogbo awọn konge ẹrọ lati kolaginni; ìwẹnumọ́; igbaradi; lyophilization; idanwo.

Alaye Furontia

Tẹle awọn aṣeyọri imọ-ẹrọ tuntun wa ati alaye gige-eti ni aaye peptide.

What ImmuPharma’s Deals Reveal About Peptide CMC Strategy

What ImmuPharma’s Deals Reveal About Peptide CMC Strategy

Deconstructing ImmuPharma’s Tripartite CMC Blueprint The traditional outsourcing playbook encouraged biotechs to consolidate early-stage programs under one primary vendor to simplify contract

What ImmuPharma’s Moves Reveal About Peptide CMC Strategy

What ImmuPharma’s Moves Reveal About Peptide CMC Strategy

Deconstructing the Tripartite CMC Ecosystem Building a multi-partner network requires mapping each vendor’s core competency to specific phase-gate deliverables. In the case

What Lonza’s Margin Hike and ADC Deal Mean for Peptide Developers

What Lonza’s Margin Hike and ADC Deal Mean

Decoding the Market Signals: Margin Elevation and the ADC Consolidation Wave To evaluate how big-pharma CDMO strategies impact pipeline execution, developers must

Olubasọrọ ati Iranlọwọ

Beere ohunkohun ninu aaye peptide.

Kan si amoye peptide kan

Ṣe iwiregbe ni iyara nipasẹ whatsapp tabi fi awọn iwulo ati awọn ibeere rẹ silẹ nipasẹ fọọmu naa.

Awọn ibeere FAQ

Ṣayẹwo awọn FAQ wa fun iraye si iyara si alaye.

Ile Wa Whatsapp Awọn iṣẹ Ọja